Cargando…
MOR Is Not Enough: Identification of Novel mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens
The mu-opioid receptor (MOR) is the G-protein coupled receptor primarily responsible for mediating the analgesic and rewarding properties of opioid agonist drugs such as morphine, fentanyl, and heroin. We have utilized a combination of traditional and modified membrane yeast two-hybrid screening met...
Autores principales: | Petko, Jessica, Justice-Bitner, Stephanie, Jin, Jay, Wong, Victoria, Kittanakom, Saranya, Ferraro, Thomas N., Stagljar, Igor, Levenson, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695902/ https://www.ncbi.nlm.nih.gov/pubmed/23840749 http://dx.doi.org/10.1371/journal.pone.0067608 |
Ejemplares similares
-
Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence
por: Jin, Jay, et al.
Publicado: (2010) -
Split-Ubiquitin Based Membrane Yeast Two-Hybrid (MYTH) System: A Powerful Tool For Identifying Protein-Protein Interactions
por: Snider, Jamie, et al.
Publicado: (2010) -
Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia
por: Oladosu, Folabomi A., et al.
Publicado: (2015) -
Role of efficacy as a determinant of locomotor activation by mu‐opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR‐selective phenylmorphans with high‐to‐low MOR efficacy
por: Santos, Edna J., et al.
Publicado: (2023) -
Association of Mu-Opioid Receptor(MOR) Expression and Opioids Requirement With Survival in Patients With Stage I-III Pancreatic Ductal Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2021)